HIGHLIGHTS OF PRESCRIBING INFORMATION
These highlights do not include all the information needed to use LEVOPHED safely and effectively. See full prescribing information for LEVOPHED.
LEVOPHED® (norepinephrine bitartrate) injection, for intravenous use
Initial U.S. Approval: 1950
INDICATIONS AND USAGE
LEVOPHED is a catecholamine indicated for restoration of blood pressure in adult patients with acute hypotensive states. (1)
DOSAGE AND ADMINISTRATION
DOSAGE FORMS AND STRENGTHS
Injection: 4 mg/4 mL (1 mg/mL) norepinephrine base in single-dose glass vial or ampule. (3)
WARNINGS AND PRECAUTIONS
Most common adverse reactions are ischemic injury, bradycardia, anxiety, transient headache, respiratory difficulty, and extravasation necrosis at injection site. (6)
To report SUSPECTED ADVERSE REACTIONS, contact Pfizer Inc. at 1-800-438-1985, or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
USE IN SPECIFIC POPULATIONS
See 17 for PATIENT COUNSELING INFORMATION.
LEVOPHED® NOREPINEPHRINE BITARTRATE, Vial U.S. Physician Prescribing Information (norepinephrine bitartrate injection, USP) Highlights
Did you find an answer to your question?